Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
Company news
Company news
2024,04,27
Joint drugs have seen steady growth in revenue for many years, and fish oil health products have emerged as a rising star. Securities Times
2024,04,27
Realize a net profit of 163 million yuan in 2023 and adhere to a high proportion of dividends to give back to investors
2024,04,21
Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors
Cheng Yi
Company notice
Company news
Media coverage
2023,10,27
Chengyi Pharmaceutical Industry Layout "Life and Health Industry"
2023,10,07
Chengyi Pharmaceutical: Striving to Build a "Sincere Territory" of the Life and Health Industry
2023,08,25
Chengyi Pharmaceutical's Midterm Performance Exceeds Expectations and Continues to Increase Online and Offline Promotion Efforts
2023,08,23
Chengyi Pharmaceutical : The net profit for the half year of 2023 is approximately 90.6 million yuan, an increase of 39.48% year-on-year
2023,07,22
Chengyi Pharmaceutical Announces the "Gathering Call" for Production and Operation in the Second Half of the Year
2023,06,01
Cheng Yi Pharmaceutical Conquers High Purity Medicinal Fish Oil Technology
2023,04,28
Chengyi and Chengmei Sign "Ultra Pure Fish Oil", Entering the First Order of Hainan Free Trade Port
2023,04,26
Cheng Yi : Achieve a revenue of 655 million yuan in 2022 to support development
2023,04,15
There is nothing small about national security, national security is around us
2023,03,13
71 students from the "Chengyi Class" of China Pharmaceutical University have graduated!
2023,01,16
Provincial Medical Security Bureau to Dongtou, Wenzhou
2022,12,13
Cheng Yi pharmaceutical industry's characteristic party building measures lead the innovative development of enterprises
<
1
2
3
...
11
>
Contact Us
view more